DaVita Inc
NYSE:DVA
Relative Value
The Relative Value of one DVA stock under the Base Case scenario is 249.5 USD. Compared to the current market price of 136.87 USD, DaVita Inc is Undervalued by 45%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
DVA Competitors Multiples
DaVita Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
DaVita Inc
NYSE:DVA
|
12.2B USD | 1 | 17.7 | 8.6 | 12.6 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
93.5B EUR | 0.5 | 19.5 | 10.1 | 13.4 | |
US |
Cigna Corp
NYSE:CI
|
100.1B USD | 0.5 | 19.4 | 10 | 13.4 | ||
US |
CVS Health Corp
NYSE:CVS
|
69.4B USD | 0.2 | 9.5 | 8.6 | 8.6 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | 0.7 | -26.4 | 10.1 | 22.5 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 1.4 | 39 | 11.9 | 17.9 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 1.6 | 18 | 10.8 | 14.6 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 0.6 | 23.9 | 7 | 16.6 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.6 | 23.3 | 6.9 | 16.4 | |
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 | ||
US |
Chemed Corp
NYSE:CHE
|
8.6B USD | 3.8 | 30.5 | 19.1 | 22.3 |